Weight loss drug is not taking easy way out

There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...